Evaluation of colorimetric methods using nicotinamide for rapid detection of pyrazinamide resistance in mycobacterium tuberculosis

Journal of Clinical Microbiology

Volumn 48, Issue 8, 2010, Pages 2729-2733

  Mirabal, Niuris C ^a   Yzquierdo, Sergio L ^a   Lemus, Dihadenys ^a   Madruga, Mariela ^a   Milián, Yoslaine ^a   Echemendía, Miguel ^a   Takiff, Howard ^b   Martin, Anandi ^c   Van Der Stuyf, Patrick ^c   Palomino, Juan Carlos ^c   Montoro, Ernesto ^a  

^a INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^b INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

^c INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; MALACHITE GREEN; NICOTINAMIDE; NITRATE REDUCTASE; PYRAZINAMIDASE; PYRAZINAMIDE; UNCLASSIFIED DRUG; AMIDASE; MALACHITE; NITRIC ACID DERIVATIVE; ORGANOMETALLIC COMPOUND; PNCA PROTEIN, MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; COLORIMETRY; CONTROLLED STUDY; ENZYME ACTIVITY; GENE MUTATION; GENE SEQUENCE; GOLD STANDARD; INTERMETHOD COMPARISON; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PNCA GENE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; COMPARATIVE STUDY; DNA SEQUENCE; DRUG EFFECTS; EVALUATION STUDY; GENETICS; HUMAN; METABOLISM; MICROBIAL SENSITIVITY TEST; PROCEDURES;

AMIDOHYDROLASES; ANTITUBERCULAR AGENTS; COLORIMETRY; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; NIACINAMIDE; NITRATES; ORGANOMETALLIC COMPOUNDS; PYRAZINAMIDE; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA;

MYCOBACTERIUM TUBERCULOSIS;

EID: 77955446850     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00311-10     Document Type: Article

References (38)

1. Angeby, K. A., L. Klintz, and S. E. Hoffner. 2002. Rapid and inexpensive drug susceptibility testing of Mycobacterium tuberculosis with a nitrate reductase assay. J. Clin. Microbiol. 40:553-555.
2. Barco, P., R. F. Cardoso, R. D. C. Hirata, C. Q. F. Leite, J. R. Pandolfi, D. N. Sato, M. L. Shikama, F. Fiúza de Melo, E. M. Mamizuka, P. A. Z. Campanerut, and M. H. Hirata. 2006. pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates from the southeast region of Brazil. J. Antimicrob. Chemother. 58:930-935.
3. Brander, E. 1972. A simple way of detecting PZA resistance. Tubercle 53:128-131.
4. Farnia, P., M. Reza, F. Mohammadi, P. Tabarsei, P. Farnia, A. R. Mohammadzadeh, P. Baghei, M. Varahram, S. Hoffner, and A. A. Velayati. 2008. Colorimetric detection of multidrug-resistant or extensively drug-resistant tuberculosis by use of malachite green indicator dye. J. Clin. Microbiol. 46:796-799.
5. Heifets, L. 2002. Susceptibility testing of Mycobacterium tuberculosis to PZA. J. Med. Microbiol. 51:11-12.
6. Heifets, L., and P. Lindholm-Levy. 1992. Pyrazinamide sterilizing activity in vitro against semidormant Mycobacterium tuberculosis bacterial populations. Am. Rev. Respir. Dis. 145:1223-1225.
7. Hirano, K., M. Takahashi, Y. Kaumi, Y. Fukasawa, and C. Abe. 1997. Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis. Tuber. Lung Dis. 78:117-122.
8. Huang, T. S., S. S. J. Lee, H. Z. Tu, W. K. Huang, Y. S. Chen, C. K. Huang, S. R. Wann, H. H. Lin, and Y. C. Liu. 2003. Correlation between pyrazinamide activity and pncA mutations in Mycobacterium tuberculosis isolates in Taiwan. Antimicrob. Agents Chemother. 47:3672-3673.
9. Jones, J. J., and J. O. Falkinham. 2003. Decolorization of malachite green and crystal violet by waterborne pathogenic mycobacteria. Antimicrob. Agents Chemother. 47:2323-2326.
10. Juréen, P., J. Werngren, J. C. Toro, and S. Hoffner. 2008. Pyrazinamide resistance and pncA gene mutations in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 52:1852-1854.
11. Kalich, R., W. Gerloff, R. Neubert, and H. Ulber. 1978. Determination of the sensitivity of mycobacteria to pyrazinamide and nicotinamide. Z. Erkr. Atmungsorgane. 151:103-112.
12. Konno, K., F. M. Feldman, and W. McDermott. 1967. Pyrazinamide susceptibility and amidase activity of tubercle bacilli. Am. Rev. Respir. Dis. 95: 461-469.
13. Krishnamurthy, A., D. Almeida, C. Rodrigues, and A. Mehta. 2004. Comparison of pyrazinamide drug susceptibility of Mycobacterium tuberculosis by radiometric BACTEC and enzymatic pyrazinamidase assay. Indian J. Med. Microbiol. 22:166-168.
14. Kruuner, A., M. D. Yates, and F. A. Drobniewski. 2006. Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first- and second-line antimicrobial drugs with drug-resistant clinical strains of Mycobacterium tuberculosis. J. Clin. Microbiol. 44:811-818.
15. Lee, K. W., J. Lee, and K. Jung. 2001. Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Korea. J. Korean Med. Sci. 16:537-543.
16. Lemus, D., A. Martin, E. Montoro, F. Portaels, and J. C. Palomino. 2004. Rapid alternative methods for detection of rifampicin resistance in Mycobacterium tuberculosis. J. Antimicrob. Chemother. 54:130-133.
17. Lemus, D., E. Montoro, M. Echemendía, A. Martin, F. Portaels, and J. C. Palomino. 2006. Nitrate reductase assay for detection of drug resistance in Mycobacterium tuberculosis: simple and inexpensive method for low-resource laboratories. J. Med. Microbiol. 55:861-863.
18. Martin, A., A. Cubillos-Ruiz, A. Von Groll, P. Del Portillo, F. Portaels, and J. C. Palomino. 2008. Nitrate reductase assay for the rapid detection of pyrazinamide resistance in Mycobacterium tuberculosis using nicotinamide. J. Antimicrob. Chemother. 61:123-127.
19. Martin, A., E. Montoro, D. Lemus, N. Símboli, N. Morcillo, M. Velasco, J. Chauca, L. Barrera, V. Ritacco, F. Portaels, and J. C. Palomino. 2005. Multicenter evaluation of the nitrate reductase assay for drug resistance detection of Mycobacterium tuberculosis. J. Microbiol. Methods 63:145-150.
20. Martin, A., H. Takiff, P. Vandamme, J. Swings, J. C. Palomino, and F. Portaels. 2006.Anew rapid and simple colorimetric method to detect pyrazinamide resistance in Mycobacterium tuberculosis using nicotinamide. J. Antimicrob. Chemother. 58:327-331.
21. Martin, A., S. Panaiotov, F. Portaels, S. Hoffner, J. C. Palomino, and K. Angeby. 2008. The nitrate reductase assay for the rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. J. Antimicrob. Chemother. 62:56-64.
22. McClatchy, J. K., A. Y. Tsang, and M. S. Cernich. 1981. Use of pyrazinamidase activity on Mycobacterium tuberculosis as a rapid method for determination of pyrazinamide susceptibility. Antimicrob. Agents Chemother. 20:556-557.
23. McDermott, W., and R. Tompsett. 1954. Activation of PZA and nicotinamide in acidic environment in vitro. Am. Rev. Tuberc. 70:748-754.
24. McKenzie, D., L. Malone, and S. Kushner. 1948. The effect of nicotinic acid amide on experimental tuberculosis of white mice. J. Lab. Clin. Med. 33: 1249-1253.
25. Mengatto, L., Y. Chiani, and M. S. Imaz. 2006. Evaluation of rapid alternative methods for drug susceptibility testing in clinical isolates of Mycobacterium tuberculosis. Mem. Inst. Oswaldo Cruz 101:535-542.
26. Montoro, E., D. Lemus, M. Echemendia, A. Martin, F. Portaels, and J. C. Palomino. 2005. Comparative evaluation of the nitrate reductase assay, the MTT test, and the resazurin microtitre assay for drug susceptibility testing of clinical isolates of Mycobacterium tuberculosis. J. Antimicrob. Chemother. 55:500-505. (Pubitemid 40542590)
27. Scarparo, C., P. Ricordi, G. Ruggiero, and P. Piccoli. 2004. Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide, streptomycin, isoniazid, rifampin, and ethambutol and comparison with the radiometric BACTEC 460TB method. J. Clin. Microbiol. 42:1109-1114.
28. Scorpio, A., and Y. Zhang. 1996. Mutations in pncA, a gene encoding pyrazinamidase/ nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat. Med. 2:662-667.
29. Scorpio, A., P. Lindholm-Levy, L. Heifets, R. Gilman, S. Siddiqi, M. Cynamon, and Y. Zhang. 1997. Characterization of pncA mutations in PZA-resistant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 41: 540-543.
30. Siddiqui, S. 2004. BACTEC 460TB system-indirect susceptibility tests with pyrazinamide for Mycobacterium tuberculosis, p. 7.8.2.1-7.8.2.3. In H. D. Isenberg (ed.), Clinical microbiology procedures handbook, 2nd ed., vol. 2. ASM Press, Washington, DC.
31. Singh, P., C. Wesley, G. P. S. Jadaun, S. K. Malonia, R. Das, P. Upadhyay, J. Faujdar, P. Sharma, P. Gupta, A. K. Mishra, K. Singh, D. S. Chauhan, V. D. Sharma, U. D. Gupta, K. Venkatesan, and V. M. Katoch. 2007. Comparative evaluation of Löwenstein-Jensen proportion method, BacT/ALERT 3D system, and enzymatic pyrazinamidase assay for pyrazinamide susceptibility testing of Mycobacterium tuberculosis. J. Clin. Microbiol. 45:76-80.
32. Sreevatsan, S., X. Pan, Y. Zhang, B. N. Kreiswirth, and J. M. Musser. 1997. Mutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organisms. Antimicrob. Agents Chemother. 41: 636-640.
33. Syre, H., S. Phyu, P. Sandven, B. Bjorvatn, and H. M. S. Grewal. 2003. Rapid colorimetric method for testing susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin in liquid cultures. J. Clin. Microbiol. 41:5173-5177.
34. van Soolingen, D., P. W. M. Hermans, P. E. W. de Hass, D. R. Soll, and J. D. A. van Embden. 1991. Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. J. Clin. Microbiol. 29:2578-2586.
35. Wayne, L. G. 1974. Simple pyrazinamidase and urease tests for routine identification of mycobacteria. Am. Rev. Respir. Dis. 109:147-151.
36. World Health Organization. 2008. Global tuberculosis control: surveillance, planning, financing. WHO report 2008. WHO/HTM/TB/2008.393. World Health Organization, Geneva. Switzerland.
37. Zhang, Y., A. Scorpio, H. Nikaido, and Z. Sun. 1999. Role of acid pH and deficient efflux of pyrazinoic acid in unique susceptibility of Mycobacterium tuberculosis to pyrazinamide. J. Bacteriol. 181:2044-2049.
38. Zimhony, O., C. Vilchèze, M. Arai, J. T. Welch, and W. R. Jacobs, Jr. 2007. Pyrazinoic acid and its n-propyl ester inhibit fatty acid synthase type I in replicating tubercle bacilli. Antimicrob. Agents Chemother. 51:752-754.